RESUMO
We have analyzed and compared in detail the malignant phenotypes of, the immune mechanisms induced by, and the immunotherapeutic potentials of B16-F10.9 melanoma cells manipulated by gene transfer to express syngeneic H-2Kb molecules or to secrete the cytokines interleukin 2 (IL-2) or IL-6. Local tumor growth in the footpad of transduced cells is mainly retarded by expression of H-2Kb and IL-2 genes and less by expression of IL-6. Mice given injections intrafootpad of tumorigenic doses of transduced clones manifested significantly reduced postsurgical spontaneous metastasis. After i.v. inoculation, mice given injections of F10.9-Kb expressors did not develop experimental lung metastases; mice given injections of F10.9-IL-6 secretors developed reduced metastatic loads; whereas mice given injections of F10.9-IL-2 secretors developed high loads of lung metastases. On the basis of injections into nude mice, in vivo depletions of CD4+, CD8+, and NK1.1+ cells, and in vitro CTL and natural killer (NK) assays, we show that all F10.9-modified cells induce CD8+ tumor-specific CTL activity and that F10.9-IL-2 secretors also induce nonspecific NK/lymphokine-activated killer cell activity. Vaccinations with F10.9-modified cells were capable of significantly reducing metastatic spread from small established F10.9 footpad tumors. However, in mice carrying preestablished lung metastases, a highly therapeutic effect was achieved only when H-2Kb expressors and IL-2 secretors were combined in vaccination, whereas individual vaccines or other combinations had marginal effects. This higher efficiency of the combined vaccine is due to the combined effect of efficient CTL induction and NK/lymphokine-activated killer cell activity as concluded from depletion of CD8+ and NK1.1 cells during immunotherapy. Thus, the cure of established metastasis can be achieved by the synergistic effects of vaccination with class I and IL-2-transduced tumor cells.
Assuntos
Terapia Genética , Antígenos H-2/imunologia , Interleucina-2/imunologia , Neoplasias Pulmonares/secundário , Neoplasias Pulmonares/terapia , Melanoma Experimental/imunologia , Melanoma Experimental/terapia , Animais , Técnicas de Transferência de Genes , Antígenos H-2/genética , Imunoterapia Ativa , Interleucina-2/genética , Interleucina-2/metabolismo , Interleucina-6/genética , Interleucina-6/imunologia , Interleucina-6/metabolismo , Células Matadoras Ativadas por Linfocina/imunologia , Células Matadoras Naturais/imunologia , Neoplasias Pulmonares/cirurgia , Melanoma Experimental/genética , Camundongos , Camundongos Endogâmicos C57BL , Transplante de Neoplasias , Fenótipo , Complicações Pós-Operatórias/imunologia , Linfócitos T Citotóxicos/imunologia , Transdução Genética , Vacinas Combinadas/farmacologiaRESUMO
To investigate the influence of interleukin 6 (IL-6) production on malignancy of tumor cells we transfected cells of the high-metastatic, low-immunogenic D122 clone of the Lewis lung carcinoma with a mammalian expression vector containing the human IL-6 complementary DNA. In vitro, IL-6 positive transfectants showed growth inhibition that was directly correlated with the levels of IL-6 production. The in vitro growth arrest did not seem to be a function of an autocrine system mediated via the secreted human IL-6 acting on the tumor cell surface receptors since neutralizing antibodies to human IL-6 did not prevent the growth inhibition. Neither did exogenous human recombinant IL-6 affect the growth of D122 cells. In vivo, IL-6 positive transfectants showed reduction of tumorigenicity and significant suppression of metastatic competence in syngeneic, immunocompetent mice. In mature T-cell deficient nude mice, the IL-6 transfectants showed some arrest of local growth but no suppression of lung metastasis. It seems therefore that the reduction of metastatic competence of IL-6 transfectants is primarily a function of stimulation by the transfectants of host T-cell immune responses. Immunization with inactivated high-positive IL-6 transfectants induced high levels of anti-tumor cytotoxic T-lymphocytes and protected mice against metastatic growth of a subsequent graft of parental tumor cells. Moreover, reduction of metastatic growth of parental highly metastatic D122 cells was also achieved when immunization of mice was begun after establishment of the primary parental tumors. Thus, inactivated IL-6 transfectants were effective when used as a cellular vaccine for experimental immunotherapy of metastasis.
Assuntos
Interleucina-6/genética , Metástase Neoplásica , Neoplasias Experimentais/terapia , Transfecção , Adolescente , Animais , Humanos , Imunoterapia , Neoplasias Pulmonares/terapia , Camundongos , Camundongos Endogâmicos C57BL , Fenótipo , Linfócitos T Citotóxicos/imunologiaRESUMO
The high incidence of spontaneous T cell lymphomas in AKR mice (affected by sustained viremia) can be greatly reduced by experimental manipulations including thymus removal at young age or by genetic manipulation changing the Fv-1 allele that controls replication and spread of viruses (establishing the congenic AKR.Fv-1b mice). Although T cell lymphomagenesis is prevented, all these mice were shown to carry endogenous ecotropic provirus-induced potential lymphoma cells (PLCs) in a dormant state. The termination of the dormant state, leading to a high incidence of CD5+ IgM+ B cell lymphomas, was triggered by interference with T cell functions (optimal effect observed following in vivo administration of anti-CD8 moAb), administration of T cell growth factors or by injecting the MCF-247 recombinant virus isolate (from AKR origin) that affects T cell functions. The assumption that the PLC dormant state is maintained through specific immunological mechanisms (involving T cells or antibodies recognizing PLCs) could not be substantiated experimentally. The results of the present studies suggest that T cells provide immunoregulatory signals or factors that contribute to the maintenance of the B cell lymphoma arrest and/or proliferation. Analysis of cytokine levels produced by splenocytes taken from mice during PLC dormancy or its breakdown indicated reduced levels of IL-2 and IL-4 and marked elevation of IL-1 and IL-6 associated with the termination of the dormant state. The effect of IL-1 and IL-6 on terminating the dormant state was demonstrated by injecting these cytokines into PLC carriers, thymectomized 12-month-old AKR mice, yielding 80-85% CD5+ IgM+ B cell lymphomas. The role of IL-6 on B cell lymphoma proliferation was also indicated in MCF-247 mediated termination of dormancy, by inhibiting significantly its effect via in vivo administration of anti IL-6 moAbs.
Assuntos
Citocinas/biossíntese , Interleucina-1/farmacologia , Interleucina-6/farmacologia , Subpopulações de Linfócitos/imunologia , Linfoma de Células B/imunologia , Envelhecimento , Animais , Cruzamentos Genéticos , Citometria de Fluxo , Interleucina-1/biossíntese , Interleucina-2/biossíntese , Interleucina-4/biossíntese , Interleucina-6/biossíntese , Ativação Linfocitária/efeitos dos fármacos , Linfoma de Células B/genética , Linfoma de Células B/patologia , Camundongos , Camundongos Endogâmicos AKR , Camundongos Endogâmicos C57BL , Baço/imunologia , TimectomiaRESUMO
Development of cytokine gene-modified autologous tumor vaccines must take into account the strictly paracrine physiology of cytokines whose expression at the tumor microenvironment is important for the successful induction of tumor-specific immunity. In this study, we investigated the efficacy of a tumor vaccine composed of inactivated autologous cells transfected with two plasmid vectors encoding a mutant membrane-bound murine granulocyte-macrophage colony-stimulating factor (MuGM-CSF) and murine interferon-gamma (MuIFN-gamma). Expression of both cytokines as cell surface ligands on the highly metastatic D122 clone of Lewis lung carcinoma led to abrogation of their tumorigenicity and metastatic phenotype. More importantly, vaccination with irradiated tumor cells expressing the membrane-bound GM-CSF and IFN-gamma induced a cytotoxic T lymphocyte (CTL) response that protected syngeneic mice against a subsequent challenge with D122 cells as a primary tumor in preimmunized mice as well as against lung metastasis developing after surgical removal of the primary tumor in naive mice. Autologous cells expressing the membrane-bound GM-CSF and IFN-gamma exhibited comparable efficacy as an antimetastatic vaccine to a vaccine composed of transfectants expressing wild-type secreted cytokine molecules. These results indicate that membrane-bound cytokines can cause enhanced immunogenicity when transfected into tumor cells for the induction of antitumor immunity.
Assuntos
Vacinas Anticâncer/farmacologia , Citocinas/genética , Animais , Sequência de Bases , Vacinas Anticâncer/genética , Vacinas Anticâncer/imunologia , Membrana Celular/imunologia , Primers do DNA/genética , Feminino , Expressão Gênica , Fator Estimulador de Colônias de Granulócitos e Macrófagos/genética , Interferon gama/genética , Neoplasias Pulmonares/imunologia , Neoplasias Pulmonares/secundário , Neoplasias Pulmonares/terapia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Transplante de Neoplasias , Proteínas Recombinantes , Linfócitos T Citotóxicos/imunologia , Transfecção , Transplante AutólogoRESUMO
Interleukin 12 (IL-12) is a disulfide-linked heterodimer molecule produced predominantly by professional antigen presenting cells. It promotes the induction of sundry biological effects with significant relevance to antitumor immunity, such as enhancing a T(H)1 helper response, an in vivo antiangiogenic effect, induction of adhesion molecules that assist in lymphocyte homing to sites of tumor growth, and a direct stimulatory effect on both T-cells and NK cells. We tested the efficacy of an antimetastatic vaccine composed of autologous murine D122 cells transfected with both subunits of IL-12 cDNA to express biologically-active IL-12 molecule. Expression of IL-12 by D122 cells significantly reduced their tumorigenicity and metastatic potential in immunocompetent syngeneic hosts. Furthermore, vaccination of mice with 2 x 10(6) irradiated IL-12-transfected D122 cells engendered a protective CTL response which rejected a subsequent challenge with parental D122 cells and eradicated lung micrometastasis in animals whose primary tumors have been surgically removed. The antitumor effects of IL-12 were mediated primarily by its ability to induce gammaIFN expression in vivo. CD8+ T-cells as well as NK cells were crucial in the execution of the antitumor effects of IL-12. These results suggest that autologous tumor cells expressing IL-12 by gene transfer are a potent antitumor vaccine able to induce a systemic immune response against poorly immunogenic and spontaneously metastatic tumors.
Assuntos
Vacinas Anticâncer/uso terapêutico , Carcinoma Pulmonar de Lewis/prevenção & controle , Terapia Genética/métodos , Interferon gama/genética , Interleucina-12/genética , Metástase Neoplásica/prevenção & controle , Animais , Carcinoma Pulmonar de Lewis/imunologia , Carcinoma Pulmonar de Lewis/secundário , Divisão Celular , Células Cultivadas , Imunoterapia/métodos , Interleucina-12/imunologia , Células Matadoras Naturais/imunologia , Camundongos , Plasmídeos/genética , Reação em Cadeia da Polimerase , Células Th1/efeitos dos fármacos , Transfecção , Células Tumorais CultivadasRESUMO
Binding of peanut agglutinin (PNA) to normal human peripheral blood mononuclear cells was analyzed on a cell sorter, and compared to the binding of the monocyte specific monoclonal antibodies Mac-1 and Leu-M3. Each of the reagents labeled 9-11% of the mononuclear cells and similar binding patterns were observed. Of the PNA+ cells, 67% adhered to plastic petri dishes, whereas 76% of Mac-1+ cells were adherent. No competition for binding was observed between PNA and Mac-1 on the one hand, or PNA and Leu-M3 on the other. In double staining experiments, about 10% of the cells, comprising 80% of the monocytes, were PNA+ Leu-M3+. Our results show that PNA can serve for the identification and enumeration of monocytes in human peripheral blood.
Assuntos
Lectinas , Contagem de Leucócitos/métodos , Monócitos , Anticorpos Monoclonais/imunologia , Separação Celular , Humanos , Monócitos/imunologia , Aglutinina de AmendoimRESUMO
Four novel 2,4-methano amino acids (MAAs, 1-aminocyclobutane-1-carboxylic acids) were synthesized. These include the basic MAA analogs of lysine (16), ornithine (5), and arginine (6) and the neutral methanovaline (22), related to proline. The above MAAs, as well as the MAA analog of homothreonine (7), were incorporated into the peptide chain of the immunomodulatory peptide tuftsin, Thr-Lys-Pro-Arg, known to enhance several biological activities mediated by phagocytic cells. The synthetic methano tuftsin analogs were assayed for their ability to stimulate interleukin-6 (IL-6) secretion by mouse peritoneal macrophages and for their stability in human serum toward enzymatic degradation. It was found that, at 2 x 10(-7) M, [MThr1]tuftsin (24) and an isomer of [MVal3]tuftsin (27a) were considerably more active than the parent peptide in augmentation of cytokine release. [MOrn2]Tuftsin (25) was equally potent. The analogs [MThr1]tuftsin (24) and [MOrn2]tuftsin (25), both pertaining to the proteolytically sensitive Thr-Lys bond of tuftsin, exhibited high resistance to enzymatic hydrolysis as compared to tuftsin. Using specific rabbit anti-tuftsin antibodies in a competitive enzyme-linked immunosorbent assay (ELISA) revealed that none of the MAA analogs can cross-react with tuftsin. It may indicate that the peptides assume global structures different than that of tuftsin.
Assuntos
Aminoácidos Cíclicos , Aminoácidos , Peptídeos/síntese química , Peptídeos/farmacologia , Tuftsina/análogos & derivados , Aminoácidos/química , Animais , Anticorpos/imunologia , Anticorpos/metabolismo , Dicroísmo Circular , Endopeptidases/sangue , Endopeptidases/metabolismo , Ensaio de Imunoadsorção Enzimática , Humanos , Interleucina-6/metabolismo , Macrófagos Peritoneais/efeitos dos fármacos , Macrófagos Peritoneais/metabolismo , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Camundongos , Estrutura Molecular , Peptídeos/imunologia , Peptídeos/metabolismo , Tuftsina/análise , Tuftsina/farmacologiaRESUMO
Thirteen analogues of the natural macrophage activator peptide tuftsin, ten of which are novel, were synthesized with the aim of exploring the relation between their biological potency and their capacity to attach specifically to cellular tuftsin's receptors. The analogues representing modifications and chain extensions at various parts of the parent tuftsin molecule can be classified as N-terminal analogues, C-terminal analogues, "within-chain" derivatives, or dimers of tuftsin and retrotuftsin. The various synthetic routes employed to prepare the analogues are described. A direct correlation was found between the ability of analogues to inhibit [3H-Arg4]tuftsin specific binding to mice peritoneal macrophages and their capacity to enhance phagocytosis or to inhibit tuftsin-mediated phagocytosis by the cells and to potentiate the cell's immune response.
Assuntos
Tuftsina/análogos & derivados , Animais , Feminino , Macrófagos/efeitos dos fármacos , Camundongos , Fagocitose/efeitos dos fármacos , Receptores Imunológicos/efeitos dos fármacos , Relação Estrutura-Atividade , Tuftsina/síntese química , Tuftsina/farmacologiaRESUMO
In Cl2MDP-osteopetrotic mice, one subpopulation of thioglycollate-induced peritoneal exudate macrophages (M phi) is missing. This subpopulation is precisely the one whose differentiation is known to be dependent on T-lymphocytes, as it is also missing in the athymic nu/nu mice. Cl2MDP-induced osteopetrosis being partially attributable to deficient osteoclastic bone resorption, raises the possibility that this missing M phi subpopulation might represent the precursors of osteoclasts. It is suggested from this work that the interplays between T-cells and M phi, so well known in immunity and inflammation, may also be relevant to osteoclastic differentiation and therefore, to bone remodeling.
Assuntos
Ácido Clodrônico , Difosfonatos , Macrófagos/patologia , Osteopetrose/patologia , Linfócitos T/fisiologia , Animais , Líquido Ascítico , Osso e Ossos/patologia , Diferenciação Celular , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Osteopetrose/induzido quimicamente , Tioglicolatos/farmacologiaRESUMO
We have briefly reviewed our studies on the mechanisms controlling the differentiation and activation of peritoneal antigen-presenting cells. We demonstrated that the peritoneal population is composed of two main subsets of cells, only one of which participates actively in primary antigen presentation. The latter is missing in athymic mice and seems to differentiate under the influence of the shortlived, cortisone-resistant subpopulation of thymocytes. The maturation of the peritoneal macrophages is subjected also to an additional inducing effect, that of the spleen. Macrophages from splenectomized donors are impaired both with respect to antigen presentation to naive and to primed lymphocytes, and with respect to phagocytosis of "opsonized" bacteria. The mature antigen-presenting cell is subjected to activating signals deriving from the Fc-bound Ig molecule. This is mediated via a tetrapeptide, tuftsin, which is cleaved off the CH2 portion of the Ig and activates the immunogenic effect of the antigen-pulsed macrophage.
Assuntos
Antígenos/imunologia , Macrófagos/imunologia , Animais , Diferenciação Celular , Linfócitos/imunologia , Ativação de Macrófagos , Macrófagos/efeitos dos fármacos , Macrófagos/efeitos da radiação , Camundongos , Camundongos Nus , Receptores Fc/análise , Baço/imunologia , Esplenectomia , Linfócitos T/imunologia , Timo/imunologia , Tuftsina/farmacologiaRESUMO
Production of interleukin-1 and of interleukin-2 was measured in 57 splenectomized patients. 11 of them were after elective operations (aged 14-37 years, mean 24) and 46 posttraumatic (aged 20-36, mean 23) and in 20 appropriate controls. There was significant reduction of both interleukins in the splenectomized group, more evident in the elective group. The deficiency was not related to age of patient or time since splenectomy. These results support the view that a consequence of splenectomy is immunoregulatory deficit.
Assuntos
Interleucina-1/sangue , Interleucina-2/sangue , Esplenectomia , Adolescente , Adulto , Fatores Etários , Feminino , Humanos , Masculino , Fatores de TempoAssuntos
Peptídeos/fisiologia , Receptores Imunológicos , Tuftsina/fisiologia , Sequência de Aminoácidos , Animais , Antineoplásicos , Arginina , Evolução Biológica , Atividade Bactericida do Sangue , Diferenciação Celular , Movimento Celular , Regulação da Expressão Gênica , Glicoproteínas/fisiologia , Fragmentos Fc das Imunoglobulinas/imunologia , Imunoglobulinas/fisiologia , Macrófagos/imunologia , Complexo Principal de Histocompatibilidade , Camundongos , Fagócitos/fisiologia , Fagocitose , Prolina , Receptores de Superfície Celular/metabolismo , Relação Estrutura-Atividade , Linfócitos T/imunologia , Tuftsina/análogos & derivadosAssuntos
Hibridomas/metabolismo , Macrófagos/metabolismo , Receptores Imunológicos , Tuftsina/metabolismo , Animais , Antígenos/imunologia , Ligação Competitiva , Linhagem Celular , Hibridomas/imunologia , Macrófagos/imunologia , Camundongos , Camundongos Endogâmicos C3H , Fagocitose , Receptores de Superfície Celular/metabolismo , Linfócitos T/imunologiaAssuntos
Receptores de Superfície Celular/metabolismo , Receptores Imunológicos , Tuftsina/metabolismo , Animais , Ligação Competitiva , Células Cultivadas , Humanos , Marcação por Isótopo , Linfócitos/metabolismo , Macrófagos/metabolismo , Camundongos , Monócitos/metabolismo , Neutrófilos/metabolismo , Fagócitos/metabolismo , Receptores Fc/metabolismo , Trítio , Tuftsina/análogos & derivadosAssuntos
Hibridomas/imunologia , Macrófagos/imunologia , Animais , Antígenos de Superfície/análise , Diferenciação Celular , Linhagem Celular , Membrana Celular/imunologia , Membrana Celular/ultraestrutura , Células Clonais , Camundongos , Camundongos Endogâmicos C3H , Fagocitose , Plasmocitoma/imunologiaRESUMO
Previous studies have shown that a recombinant vaccine expressing four highly conserved influenza virus epitopes has a potential for a broad spectrum, cross-reactive vaccine; it induced protection against H1, H2 and H3 influenza strains. Here, we report on the evaluation of an epitope-based vaccine in which six conserved epitopes, common to many influenza virus strains are expressed within a recombinant flagellin that serves as both a carrier and adjuvant. In an HLA-A2.1 transgenic mice model, this vaccine induced both humoral and cellular responses and conferred some protection against lethal challenge with the highly pathogenic H5N1 avian influenza strain. Hence, it is expected to protect against future strains as well. The data presented, demonstrate the feasibility of using an array of peptides for vaccination, which might pave the way to an advantageous universal influenza virus vaccine that does not require frequent updates and/or annual immunizations.
Assuntos
Epitopos/imunologia , Virus da Influenza A Subtipo H5N1/imunologia , Vacinas contra Influenza/imunologia , Influenza Humana/prevenção & controle , Adjuvantes Imunológicos/farmacologia , Animais , Anticorpos Antivirais/sangue , Células Cultivadas , Feminino , Flagelina/imunologia , Humanos , Influenza Humana/imunologia , Interferon gama/biossíntese , Células Matadoras Naturais/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos ICR , Camundongos Transgênicos , Coelhos , Proteínas Recombinantes/imunologiaRESUMO
D(b-/-)xbeta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/D(b)-beta2m single chain (HHD mice) are an effective biological tool to evaluate the antitumour cytotoxic T-lymphocyte response of known major histocompatibility-restricted peptide tumour-associated antigens, and to screen for putative unknown novel peptides. We utilised HHD lymphocytes to identify immunodominant epitopes of colon carcinoma overexpressed genes. We screened with HHD-derived lymphocytes over 500 HLA-A2.1-restricted peptides derived from colon carcinoma overexpressed genes. This procedure culminated in the identification of seven immunogenic peptides, three of these were derived from the 'human 1-8D gene from interferon inducible gene' (1-8D). The 1-8D gene was shown to be overexpressed in fresh tumour samples. The three 1-8D peptides were both antigenic and immunogenic in the HHD mice. The peptides induce cytotoxic T lymphocytes that were able to kill a colon carcinoma cell line HCT/HHD, in vitro and retard its growth in vivo. One of the peptides shared by all the 1-8 gene family primed efficiently normal human cytotoxic T lymphocyte precursors. These results highlight the 1-8D gene and its homologues as putative immunodominant tumour-associated antigens of colon carcinoma.
Assuntos
Antígenos Glicosídicos Associados a Tumores , Neoplasias do Colo/genética , Neoplasias do Colo/imunologia , Interferons/química , Interferons/farmacologia , Proteínas de Membrana/genética , Peptídeos/farmacologia , Linfócitos T Citotóxicos/imunologia , Animais , Linhagem Celular Tumoral , Reações Cruzadas , Humanos , Epitopos Imunodominantes , Proteínas de Membrana/imunologia , Camundongos , Camundongos TransgênicosRESUMO
Due to the fact that many cellular proteins are extensively glycosylated, processing and presentation mechanisms are expected to produce a pool of major histocompatibility complex (MHC) class I-bound protein-derived peptides, part of which retain sugar moieties. The immunogenic properties of the presented glycosylated peptides in comparison to their non-glycosylated counterparts have not been determined clearly. We assessed the cellular immunogenicity of MUC1 (mucin)-derived peptides O-glycosylated with a Tn epitope (GalNAc) using HLA-A*0201 single chain (HHD)-transfected cell lines and transgenic mice. For part of the compounds Tn moiety did not interfere with the HLA-A*0201 binding. Moreover, part of the glycopeptides elicited effective cytotoxic responses, indicating recognition of the glycopeptide-HLA-A*0201 complex by the T cell receptor (TCR) and subsequent cytotoxic T lymphocyte (CTL) activation. The CTLs exhibited a substantial degree of cross-reactivity against target cells loaded with glycosylated and non-glycosylated forms of the same peptide. The studied (glyco)peptides showed cellular immunogenicity in both MUC1-HHD and HHD mice and induced effective lysis of (glyco)peptide-loaded target cells in CTL assays. However, the elicited CTLs did not induce selective lysis of human MUC1-expressing murine cell lines. Moreover, immunization with (glyco)peptide-loaded dendritic cells (DCs) did not induce significant immunotherapeutic effects. We conclude that Tn glycosylated MUC1-derived peptides can be presented by MHC class I molecules, and may be recognized by specific TCR molecules resulting in cytotoxic immune responses. However, the studied glycopeptides did not offer significant benefit as targets for cytotoxic immune response due apparently to (a) cross-reactivity of the elicited CTLs against the glycosylated and non-glycosylated forms of the same peptide and (b) low abundance of glycopeptides on tumour target cells.
Assuntos
Antígenos Glicosídicos Associados a Tumores/imunologia , Carcinoma/terapia , Antígenos HLA-A/imunologia , Imunoterapia/métodos , Mucina-1/imunologia , Linfócitos T Citotóxicos/imunologia , Animais , Reações Antígeno-Anticorpo , Antígenos Glicosídicos Associados a Tumores/genética , Carcinoma/imunologia , Linhagem Celular , Testes Imunológicos de Citotoxicidade , Glicopeptídeos/imunologia , Antígenos HLA-A/genética , Imunização , Camundongos , Camundongos Transgênicos , Mucina-1/genética , Transfecção/métodosRESUMO
Macrophages, given keyhole limpet hemocyanin in vitro, from normal mice initiate in culture antigen-specific T cell-mediated immune reactions. On the other hand, macrophages from nude, from adult-thymectomized, or from neonatal-thymectomized mice are impaired with respect to their capacity to signal such an antigen-specific T cell reaction. Thymocytes from hydrocortisone-treated donors, added in culture to such impaired macrophages, rendered them immunologically potent. The capacity of macrophages from adult thymectomized mice to promote the activation of antigen-specific "helper" T cells which, cooperating with B lymphocytes, would lead to antibody production, was also impaired. Thus, it appears that short-lived T lymphocytes control the maturation of macrophages up to a stage at which they can present antigen-specific T cells with antigen in an immunogenic form. We found that such T lymphocytes also control the phagocytic properties of macrophages, yet the impairment of their immunogenic properties does not seem to be derived from decreased phagocytosis.
Assuntos
Macrófagos/imunologia , Linfócitos T/imunologia , Animais , Formação de Anticorpos/efeitos dos fármacos , Líquido Ascítico/citologia , Epitopos , Feminino , Hidrocortisona/farmacologia , Linfonodos/imunologia , Cooperação Linfocítica , Macrófagos/fisiologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Fagocitose , Timo/imunologiaRESUMO
Experiments were carried out aimed at investigating the effects of anesthesia without surgery on certain functional components of the immune system. We observed that the immunogenic antigen-presenting capacity of mouse peritoneal macrophages was significantly reduced one week post-anesthesia, with either injected or inhaled anesthetic drugs. On the other hand, an augmentation of the phagocytic activities of these macrophages was manifested. Hence, the impaired immunogenic potency could not be attributed to a reduced antigen uptake. Lymphocyte transformations, i.e., response to PHA and Con A were suppressed, whereas the response to LPS was augmented.